# The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery

> **NCT01912651** · PHASE4 · RECRUITING · sponsor: **University of Michigan** · enrollment: 300 (estimated)

## Conditions studied

- Facial Defect

## Interventions

- **DRUG:** cephalexin

## Key facts

- **NCT ID:** NCT01912651
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-07
- **Primary completion:** 2028-09
- **Final completion:** 2028-09
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01912651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01912651, "The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01912651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*